NeurogesX Reports Second Quarter 2009 Results
... to effectively launch Qutenza in the European union and we are now focusing our resources on the ... Qutenza is currently approved in the European union for the treatment of neuropathic pain in ... pain. Qutenza will be marketed in the European union and certain countries in Eastern Europe, the ...EFSA Issues Positive Safety Statement for the Use of Chromium Picolinate in EU Food Supplements
... picolinate in food supplements in the European union (EU). In its safety assessment, the EFSA ... Ingredients business. Expansion into the European union is an important component of our growth strategy. ... Authority (EFSA) is the keystone of European union (EU) risk assessment regarding food and feed ...BioMed Realty Trust Announces 36,900 Square Foot Lease in Seattle With Novo Nordisk
... facility in Seattle's South Lake union market. Commenting on the project, Don Foster, ... our research, and the South Lake union market is a tremendous location that enables us ... is a testament to the strength of South Lake union -- a critical cluster for the region's preeminent ...Hoana Medical and Hawai'i Union Health and Welfare Trust Funds Partner to Fix Healthcare
... an eligible insurance benefit, several union health and welfare trust funds have decided that, ... at unprecedented levels and rising each year, the union health and welfare trust funds have taken a major ... vigilance of patients is a paid benefit for all union members, their dependents and retirees. This ...Revolutionary Healing Technology for Treating Difficult and Chronic Wounds Approved by Health Canada
... was made at the 3rd Congress of the World union of Wound Healing Societies taking place from June ... awarded a lifetime achievement award by the World union of Wound Healing Societies. Professor ... care community and also a member of the World union faculty. For more information about Oxyzyme ...Digital Union's RT1(TM) Software Creates Telegenetics Network for Region 3 Genetics Collaborative
... LOS ANGELES, Aug. 17 /PRNewswire/ -- Digital union announced today they have entered into a ... and response for healthcare operations. "Digital union is pleased to provide Region 3 and SERGG with a ... their educational efforts," said Digital union CEO Paul Niday. "We're very excited about the ...NeurogesX Announces New PDUFA Date for Qutenza(TM) New Drug Application
... neuropathic pain conditions. Qutenza is currently approved in the European union for the treatment of neuropathic pain in non-diabetic adults, either alone ... medicinal products for pain. Qutenza will be marketed in the European union and certain countries in Eastern Europe, the Middle East and Africa, by ...NeurogesX to Hold Conference Call to Discuss Second Quarter 2009 Financial Results
... neuropathic pain conditions. Qutenza is currently approved in the European union for the treatment of neuropathic pain in non-diabetic adults, either alone ... medicinal products for pain. Qutenza will be marketed in the European union and certain countries in Eastern Europe, the Middle East and Africa, by ...Sanofi-aventis Announces Second Quarter 2009 Results
... on July 28. The submission for approval of Multaq ((R)) in the European union is currently being reviewed, with approval expected during the second half ... the Commission issues a decision that is binding in all European union countries. In some countries, additional time is required for pricing and ...EU Committee Approves New Food Applications for Martek's life'sDHA(TM)
... Committee On The Food Chain and Animal Health (SCFCAH) of the European union for additional novel food approval of life'sDHA in Europe. This ... before anticipated publication in the Official Journal of the European union in the coming months. DHA omega-3 is a long-chain omega-3 fatty ...EU Committee Approves New Food Applications for Martek's life'sDHA™
... Committee On The Food Chain and Animal Health (SCFCAH) of the European union for additional novel food approval of life'sDHA in Europe. This ... before anticipated publication in the Official Journal of the European union in the coming months. DHA omega-3 is a long-chain omega-3 fatty ...Spanish Government Selects Novavax's VLP Technology for Comprehensive Flu Vaccine Solution in Spain
... marketing authorization of the VLP influenza vaccines in the European union in 2012. Additional clinical development funds will be contributed by ... and registration of VLP-based influenza vaccines in the European union and possibly other countries, including the United States. Through this ...STAAR Surgical Receives CE Mark Approval for KS-X Preloaded Hydrophobic Acrylic Lens Injector System
... this foldable intraocular (IOL) KS-X lens delivery system in the European union as well as other countries that recognize the CE Mark. It also signifies ... such plans; the success of the KS-X injector system in the European union or elsewhere, our future performance; statements of belief; and any ...NeurogesX Receives European Commission Approval for Qutenza(TM)
... NeurogesX anticipates that Qutenza will be marketed in the European union through a commercial partner. Anthony DiTonno, President and CEO, ... neuropathic pain conditions. Qutenza is currently approved in the European union for the treatment of neuropathic pain in non-diabetic adults, either alone ...ASCP Joins ACLU Lawsuit Opposing Gene Patents
... for Clinical Pathology (ASCP) has joined the American Civil Liberties union (ACLU) in a lawsuit challenging the legality of patents on human genes -- ... for Clinical Pathology (ASCP) has joined the American Civil Liberties union (ACLU) in a lawsuit challenging the legality of patents on human genes ...New Technology to Revolutionize the Way the Planet Does Business
... all the hassles that workers bring: health benefits, housing, IRS, INS, union conflicts, and cultural and language differences. If you would like ... the difficulties that workers bring: health benefits, housing, IRS, INS, union conflicts, cultural and language differences etc. Through our proprietary ...CV Therapeutics Reports 2008 Fourth Quarter and Full Year Financial Results
... Group (Menarini) for the exclusive rights to Ranexa in the European union and certain other countries. For the full year ended December 31, ... (ranolazine prolonged-release tablets) is approved for use in the European union as add-on therapy for the symptomatic treatment of patients with stable ...CSMG Technologies Announces Key Fifth U.S. Tissue Bonding/Welding Patent Approved
... approval follows the issuance of four other U.S. patents, a European union patent, in eight European countries, Ukraine, Canada and Australia with 14 ... of Bipolar Forceps Systems, recent US FDA 510(k) clearance and European union C. E. Mark certification on LTC's VAD.400 electrosurgery generator and two ...EMEA Grants Kiadis Pharma Lead Product ATIR(TM) Orphan Drug Designation
... diseases or conditions that are relatively rare in the European union and for which no satisfactory therapy is available. The orphan drug ... from user fees and a ten-year period of market exclusivity in the European union after product approval. For the complete press release please go to: ...CV Therapeutics Receives European Approval for the Brand Name Ranexa(R)
... EMEA had granted marketing authorization for ranolazine in all 27 European union (EU) member states under the brand name Latixa. "Securing approval for ... adequate exercise stress. Ranexa is also approved for use in the European union as add-on therapy for the symptomatic treatment of patients with stable ...Cardinal Health, Prime Therapeutics Sign Primary Distribution Agreement
... million members through Blue Cross and Blue Shield Plans, employer and union groups and third-party administrators. "We look forward to delivering ... its client base includes Blue Cross and Blue Shield Plans, employer and union groups, and third-party administrators. Headquartered in St. Paul, ...Genzyme Files Applications for Approval of Mozobil in the United States and Europe
... marketing applications in both the United States and the European union for Mozobil(TM) (plerixafor), a product candidate intended to enhance ... has been granted orphan drug status in the United States and European union and the pivotal trials have undergone Special Protocol Assessment by the ...BioElectronics Corporation Receives Major Orders From Italian Distributor
... this additional inventory to meet demand in Italy and other European union counties. BioElectronics is seeing demand for its product increase ... and is widely available in pharmacies across Canada. The European union has also approved ActiPatch as a Class II pulsed electromagnetic medical ...Arbios Commences Process to Seek European Marketing Approval for SEPET(TM)
... that it has commenced the marketing authorization process in the European union to pursue CE Marking the SEPET(TM) Liver Assist Device. The Company has ... protection legislation and allows sale of the product within the European union (28 countries) and the European Free Trade Association (3 countries). ...PPD Expands Global Central Lab Services into China
... central lab services into China through an exclusive agreement with Peking union Lawke Biomedical Development Limited (PUL). The agreement allows PPD to ... of the agreement, PPD invested in laboratory equipment located at Peking union Medical College in the Beijing Zhong Guan Cun Life Sciences Park, the ...Quintiles Central Lab, Clinical Development in China to Expand, Relocate to New Facility
... Plaza in Beijing, about one block from the previous lab site in the Peking union Medical College Hospital (PUMCH). The new facility expands the lab space ... Global Central Laboratories. "We would like to thank the Peking union Medical College Hospital for all that it has done to help Quintiles ...REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide
... became the first TNF-alpha inhibitor approved in the European union (EU) for the short-term treatment of severe, active Crohn's disease ... approved to treat moderately to severely active UC in the European union (EU), in patients with an inadequate response to conventional ...GeoVax Labs, Inc. Provides Clinical Studies Update
... Cancer Research Center, Seattle; the San Francisco Department of Public Health; University of Alabama, Birmingham and sites at Columbia University, union Square, and the Bronx in New York City. In South America, participants are to be enrolled in Peru at sites in Iquitos and Miraflores (Lima). ...Free Webinar on Safer Clinical Hand-Offs Offered by Compirion Healthcare
... Center at Memphis, in Tennessee. She holds an AD in nursing from Northwest Community College, a BSN from the University of Memphis, and an MSN from union University. She is an active member of the American Nursing Association and the Tennessee Nurses Association. Clinical Hand-Offs Now or ...Video of EpiDerm Skin Irritation Test (SIT) Method Now Available
... Senior Scientist at MatTek, demonstrates the detailed steps in the EpiDerm Skin Irritation Test (SIT) protocol. Dr. Kandarova, based in the European union (EU), played a central role in developing this test method, which in 2007 was subjected to a blind validation trial among four EU and US-based ...Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa
... treatment cycle. The corifollitropin alfa regimen is being developed in a GnRH antagonist protocol. Corifollitropin alfa was filed in the European union in late 2008. Corifollitropin alfa Important Safety Information The most frequently reported adverse drug reactions during treatment with ...NeurogesX Added to Russell 3000 Index
... Qutenza, a dermal patch designed to manage pain associated with peripheral neuropathic pain conditions. Qutenza is currently approved in the European union for the treatment of neuropathic pain in non-diabetic adults, either alone or in combination with other medicinal products for pain. Qutenza has been ...